Insiders Biosergen AB

Equities

BIOSGN

SE0016013460

Delayed Nasdaq Stockholm Other stock markets 06:47:07 2024-07-12 am EDT			5-day change	1st Jan Change
0.356 ^SEK	-6.07%		-4.81%	-59.55%

10:11am	Biosergen AB Announces First Patient in Biosergen Clinical Trial Treating with Biosergen for Life Threatening Fungal Infection	CI
Jun. 14	Biosergen AB Approves Board Changes	CI

Insiders

Biosergen AB Approves Board Changes	Jun. 14	CI
Biosergen AB Announces CEO Changes	Jan. 12	CI
Biosergen AB Announces Transition of Peder M. Andersen into A Chief Medical Officer Role	Jan. 12	CI
Biosergen AB Announces Lena Degling Wikingsson and Hanne Mette Dyrlie Kristensen Declines Re-Election as Board Members	23-05-31	CI
Tine Kold Olesen to Join Biosergen AB as Chief Operating Officer, Effective October 1, 2021	21-08-19	CI
Biosergen AS Appoints Gunilla Ekström as CEO	12-10-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters